These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 10082885)
1. Modulation of the neuronal nicotinic acetylcholine receptor-channel by the nootropic drug nefiracetam. Oyaizu M; Narahashi T Brain Res; 1999 Mar; 822(1-2):72-9. PubMed ID: 10082885 [TBL] [Abstract][Full Text] [Related]
2. Nootropic drug modulation of neuronal nicotinic acetylcholine receptors in rat cortical neurons. Zhao X; Kuryatov A; Lindstrom JM; Yeh JZ; Narahashi T Mol Pharmacol; 2001 Apr; 59(4):674-83. PubMed ID: 11259610 [TBL] [Abstract][Full Text] [Related]
3. Post-stroke dementia. Nootropic drug modulation of neuronal nicotinic acetylcholine receptors. Zhao X; Yeh JZ; Narahashi T Ann N Y Acad Sci; 2001 Jun; 939():179-86. PubMed ID: 11462769 [TBL] [Abstract][Full Text] [Related]
4. Effects of the nootropic drug nefiracetam on the GABAA receptor-channel complex in dorsal root ganglion neurons. Huang CS; Ma JY; Marszalec W; Narahashi T Neuropharmacology; 1996; 35(9-10):1251-61. PubMed ID: 9014140 [TBL] [Abstract][Full Text] [Related]
5. [Facilitatory actions of the cognitive enhancer nefiracetam on neuronal Ca2+ channels and nicotinic ACh receptors: their intracellular signal transduction pathways]. Yoshii M; Nishizaki T; Watabe S Nihon Yakurigaku Zasshi; 1998 Oct; 112 Suppl 1():41P-43P. PubMed ID: 10190131 [TBL] [Abstract][Full Text] [Related]
6. Nefiracetam modulates acetylcholine receptor currents via two different signal transduction pathways. Nishizaki T; Matsuoka T; Nomura T; Sumikawa K; Shiotani T; Watabe S; Yoshii M Mol Pharmacol; 1998 Jan; 53(1):1-5. PubMed ID: 9443926 [TBL] [Abstract][Full Text] [Related]
7. Nefiracetam facilitates hippocampal neurotransmission by a mechanism independent of the piracetam and aniracetam action. Nomura T; Nishizaki T Brain Res; 2000 Jul; 870(1-2):157-62. PubMed ID: 10869513 [TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal polypeptide modulation of nicotinic ACh receptor channels in rat intracardiac neurones. Cuevas J; Adams DJ J Physiol; 1996 Jun; 493 ( Pt 2)(Pt 2):503-15. PubMed ID: 8782112 [TBL] [Abstract][Full Text] [Related]
9. Nefiracetam and galantamine modulation of excitatory and inhibitory synaptic transmission via stimulation of neuronal nicotinic acetylcholine receptors in rat cortical neurons. Moriguchi S; Zhao X; Marszalec W; Yeh JZ; Fukunaga K; Narahashi T Neuroscience; 2009 May; 160(2):484-91. PubMed ID: 19272425 [TBL] [Abstract][Full Text] [Related]
10. A 'long-term-potentiation-like' facilitation of hippocampal synaptic transmission induced by the nootropic nefiracetam. Nishizaki T; Matsuoka T; Nomura T; Matsuyama S; Watabe S; Shiotani T; Yoshii M Brain Res; 1999 May; 826(2):281-8. PubMed ID: 10224305 [TBL] [Abstract][Full Text] [Related]
11. Presynaptic nicotinic acetylcholine receptors as a functional target of nefiracetam in inducing a long-lasting facilitation of hippocampal neurotransmission. Nishizaki T; Matsuoka T; Nomura T; Kondoh T; Watabe S; Shiotani T; Yoshii M Alzheimer Dis Assoc Disord; 2000; 14 Suppl 1():S82-94. PubMed ID: 10850735 [TBL] [Abstract][Full Text] [Related]
12. Potentiation of N-methyl-D-aspartate-induced currents by the nootropic drug nefiracetam in rat cortical neurons. Moriguchi S; Marszalec W; Zhao X; Yeh JZ; Narahashi T J Pharmacol Exp Ther; 2003 Oct; 307(1):160-7. PubMed ID: 12805478 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of neuronal calcium channel currents by the nootropic agent, nefiracetam (DM-9384), in NG108-15 cells. Yoshii M; Watabe S Brain Res; 1994 Apr; 642(1-2):123-31. PubMed ID: 8032872 [TBL] [Abstract][Full Text] [Related]
14. Unique mechanism of action of Alzheimer's drugs on brain nicotinic acetylcholine receptors and NMDA receptors. Narahashi T; Marszalec W; Moriguchi S; Yeh JZ; Zhao X Life Sci; 2003 Dec; 74(2-3):281-91. PubMed ID: 14607256 [TBL] [Abstract][Full Text] [Related]
15. The anti-dementia drug nefiracetam facilitates hippocampal synaptic transmission by functionally targeting presynaptic nicotinic ACh receptors. Nishizaki T; Nomura T; Matuoka T; Kondoh T; Enikolopov G; Sumikawa K; Watabe S; Shiotani T; Yoshii M Brain Res Mol Brain Res; 2000 Aug; 80(1):53-62. PubMed ID: 11039729 [TBL] [Abstract][Full Text] [Related]
16. Nefiracetam potentiates N-methyl-D-aspartate (NMDA) receptor function via protein kinase C activation and reduces magnesium block of NMDA receptor. Moriguchi S; Shioda N; Maejima H; Zhao X; Marszalec W; Yeh JZ; Fukunaga K; Narahashi T Mol Pharmacol; 2007 Feb; 71(2):580-7. PubMed ID: 17095583 [TBL] [Abstract][Full Text] [Related]
17. Nonselective cationic currents activated by acetylcholine in swine tracheal smooth muscle cells. Yamashita T; Kokubun S Can J Physiol Pharmacol; 1999 Oct; 77(10):796-805. PubMed ID: 10588484 [TBL] [Abstract][Full Text] [Related]
18. Cellular mechanism of action of cognitive enhancers: effects of nefiracetam on neuronal Ca2+ channels. Yoshii M; Watabe S; Murashima YL; Nukada T; Shiotani T Alzheimer Dis Assoc Disord; 2000; 14 Suppl 1():S95-102. PubMed ID: 10850736 [TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid potentiates ACh receptor currents by G-protein-mediated activation of protein kinase C. Nishizaki T; Sumikawa K Brain Res Mol Brain Res; 1997 Oct; 50(1-2):121-6. PubMed ID: 9406926 [TBL] [Abstract][Full Text] [Related]